文献速递放疗物理与技术姑息放疗与转移瘤

COVID-19大流行对高流行区放射肿瘤临床决策的影响

Impact of the Coronavirus Disease of 2019 Pandemic on Radiation Oncology Clinical Decision Making in a High-Prevalence Environment.
PubMed 文献 · Adv Radiat Oncol · 2021-03-04

本研究回顾性分析了美国新泽西州3个放射肿瘤科在COVID-19初期激增期间接诊的545例癌症患者,其中18.1%经历至少1次COVID相关诊疗变更,放疗延迟最常见(占51.5%),医师主导的延迟占41.2%。患者年龄、治疗意图和癌症类型与COVID相关诊疗变更显著相关。

要点

  • 545例患者中18.1%经历COVID相关诊疗变更,放疗延迟最常见。
  • 医师主导的延迟占放疗延迟的41.2%,患者恐惧占27.5%。
  • 年龄、治疗意图和癌症类型与诊疗变更显著相关。

核心结论

  • COVID-19大流行期间放射肿瘤诊疗发生变更,高龄、根治性意图和直肠癌患者更易经历变更。

研究设计与样本

  • 回顾性综述,纳入美国新泽西州Rutgers Robert Wood Johnson Barnabas Health系统3个放射肿瘤科在COVID-19初期激增期间接诊的所有患者,共545例。

主要发现

  • 545例患者中99例(18.1%)经历至少1次COVID相关诊疗变更。
  • 放疗延迟占所有诊疗变更的51.5%,其中医师主导的延迟占41.2%,患者恐惧、COVID检测和获取障碍分别占27.5%、17.6%和13.7%。
  • 患者年龄(P = .040)、治疗意图(P = .047)和癌症类型(P < .001)与经历COVID相关诊疗变更显著相关。
  • 多变量分析中,控制治疗意图和癌症类型后,患者年龄仍显著。
  • 老年、根治性意图和直肠癌患者更可能经历诊疗变更。

临床怎么用

  • 大流行期间需关注高龄、根治性意图和直肠癌患者的放疗决策变更。
  • 医师应权衡延迟放疗的风险与COVID-19暴露风险,尤其对姑息放疗患者。

局限性

  • 原文未明确报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study aimed to define how the coronavirus disease of 2019 (COVID-19) pandemic affected the role, timing, and delivery of radiation therapy (RT) in a high-prevalence region at the height of the initial U.S. outbreak. METHODS AND MATERIALS: We performed a retrospective review of all patients seen at 3 radiation oncology departments within the Rutgers Robert Wood Johnson Barnabas Health system in New Jersey during the initial COVID-19 surge. The primary endpoints were to define and quantify COVID-related, radiation-specific care changes, and identify predictive factors of experiencing COVID-related care changes. RESULTS: A total of 545 patients with cancer were seen during the study period, 99 of whom (18.1%) experienced ≥1 COVID-related care change. RT delays were the most common, accounting for 51.5% of all care changes. Physician-directed delays accounted for 41.2% of RT delays, and patient fears, COVID testing, and access barriers were responsible for 27.5%, 17.6%, and 13.7%, respectively. Patient age (P = .040), intent of treatment (P = .047), and cancer type (P < .001) were significantly associated with experiencing a COVID-related care change, as we found that older, curative intent and patients with rectal cancer were more likely to experience care changes. On multivariate analysis, patient age remained significant when controlling for treatment intent and cancer type. CONCLUSIONS: Our study provides a perspective on how care was adapted to protect patients with cancer during a pandemic while maximizing disease control. The positive correlation between age and likelihood of care changes may reflect extra precaution taken with older patients given their vulnerability to severe COVID illness. The lower observed likelihood of COVID-related care changes among patients undergoing palliative RT may reflect either the more urgent needs addressed by palliative RT or simply be logistical, because palliative radiation is often delivered in short courses with less exposure risk. Assessing adaptations others have implemented and monitoring how they affect patient outcomes will be crucial.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Pendyala P, Goglia AG, Mattes MD, et al. Impact of the Coronavirus Disease of 2019 Pandemic on Radiation Oncology Clinical Decision Making in a High-Prevalence Environment. Adv Radiat Oncol. 2021. PMID: 33686375. doi:10.1016/j.adro.2021.100680

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。